1Fiorelli M,Bastianello S,van Kummer R,et al.Hemorrhagic transformation within 36 hours of a cerebral infarct:relationships with early clinical deterioration and 3-month outcome in the European Cooperative Acute Stroke Study 1 (ECASS 1) cohort[J].Stroke,1999,30(11):2280-2284.
2Rosell A,Ortega-Aznar A,Alvarez-Sabín J,et al.Increased brain expression of matrix metallopreteinase-9 after ischemic and hemorrhagic human stroke[J].Stroke,2006,37 (6):1399-1406.
3Rosell A,Cuadrado E,Ortega-Aznar A,et al.MMP-9-positive neutrophil infiltration is associated to blood-brain barrier breakdown and basal lamina type Ⅳ collagen degradation during hemorrhagic transformation after human ischemic stroke[J].Stroke,2008,39(4):1121-1126.
4Asahi M,Asahi K,Wang X,et al.Reduction of tissue plasminogen activatorinduced hemorrhage and brain injury by free radical spin trapping after embolic focal cerebral ischemia in rats[J].J Cereb Blood Flow Metab,2000,20(3):452-457.
5Murata Y,Rosell A,Scannevin R H,et al.Extension of the thrombolytic time window with minocycline in experimental stroke[J].Stroke,2008,39 (12):3372-3377.
6Castellanos M,Leira R,Serena J,et al.Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke[J].Stroke,2004,35 (7):1671-1676.
7Cocho D,Borrell M,Martí-Fáthregas J,et al.Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator[J].Stroke,2006,37 (4):996-999.
8Domoki F,Perciaccante J V,Veltkamp R,et al.Mitochoadrial potassium channel opener diazoxide preserves neuronalvascular function after cerebral ischemia in newborn pigs[J].Stroke,1999,30 (12):2713-2718,discussion 2718-2179.
9Montaner J,Femández-Cadenas I,Molina C A,et al.Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene[J].Stroke,2003,34 (12):2851-2855.
10Fernandez-Cadenas I,Alvarez-Sabin J,Ribo M,et al.Influence of thrombinactivatable fibrinolysis inhibitor and plasminogen activator inbibitor-l gene polymorphisms on tissue-type plasminogen activator-induced recanalization in ischemic stroke patients[J].J Thromb Haemost,2007,5 (9):1862-1868.
10Antithrombotic Trialists Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy forprevention of death,myocardial infartion,and stroke in highrisk patients[J].BMJ,2002,324(1):141.
